- Bayer Vietnam collaborates with the Women's Charity Association of Ho Chi Minh City (WOCA) to hand out 300 packages to support disadvantaged families and electronic tablets to children in shelters in Ho Chi Minh City.
- Activity is part of the “Strengthen Resilience of Vulnerable People in Vietnam” program, affirming Bayer's efforts to realize the vision of "Health for All, Hunger for None".
Ho Chi Minh City, July 7, 2022 - Bayer Vietnam, in collaboration with the Women’s Charity Association of Ho Chi Minh City (WOCA), handed out food and educational equipment packages to support the vulnerable community in HCMC on July 7. The event took place at the Cultural Center of District 11 with the attendance of representatives from HCMC authorities, the District Women’s Union, WOCA and volunteers from Bayer Vietnam, as well as 300 needy households and children in the city. This is part of the “Strengthen Resilience of Vulnerable People in Vietnam” project which was initiated by WOCA and Bayer Viet Nam in January 2022.
The pandemic is gradually receding but has left lasting negative impacts on society. The number of households struggling to put enough food on the table spiked as the pandemic's economic effects took hold. The relief packages from WOCA and Bayer, consisting of necessities such as rice, noodles, cooking oil and spices, are expected to mitigate hunger levels and the hardships facing some communities in need. In addition, the project has also provided and 28 electronic tablets to children in homeless shelters to enable their access to better education.
Ingo Brandenburg, Managing Director of Bayer Vietnam, shared: “At Bayer, we want to contribute to a world where everyone has access to enough food and can live a healthy life. That is why we collaborate with many trusted partners in non-profit areas to support charitable activities and social projects. Recognizing the current societal challenges of Vietnam, Bayer continues to join hands with WOCA in offering relief measures, including philanthropic giving and volunteering, to disadvantaged groups to urgently reduce their burden, and encourage them to stay optimistic and keep moving forward through tough times. With this, Bayer Vietnam once again underlines our commitment to contributing to society’s future viability, in line with our vision of “Health for All, Hunger for None”.
Since January 2022, the “Strengthen Resilience of Vulnerable People in Vietnam” project has provided 1000 relief packages of necessities, essential medical devices, medicines, learning equipment and monetary support to vulnerable families in Ho Chi Minh City, Long An and Hau Giang provinces, helping them stabilize their lives and invest in their own growth on their own terms.
“WOCA is grateful that the program has been completed successfully, easing the hardships facing many families who are struggling to make a living. We deeply appreciate Bayer Vietnam’s efforts and contributions to this meaningful project and look forward to continuous collaboration on future community projects. Through this project, we hope that the goodwill and commitment of Bayer Vietnam towards corporate social responsibility will be acknowledged and adopted by other businesses,” Ms. Nguyen Thi Hue, WOCA president, said.
A better future takes root in strong communities. In alignment with the company’s purpose ‘Science for a better life’, corporate social responsibility at Bayer goes beyond charitable giving to include its commitments to supporting initiatives that tackle the root-cause of public issues and ideas with potential to make a lasting impact for change. Thus, the company is building partnerships and implementing programs to not only extend its hand in support, but to expand its collective reach in building a better world for—and alongside—everyone.
Particularly in Vietnam, Bayer has had positive impacts on the lives of local people through targeted strategic investments in the areas of science and education, health, social needs and community projects. Besides the joint charitable project with WOCA, Bayer Vietnam has a long history of partnerships with Oxford University Clinical Research Unit (OUCRU) to develop and promote the ‘Making Science Make Sense" program, a science, technology, engineering and math (STEM) education initiative aimed at educating, engaging and inspiring the next generation of Vietnamese scientists, engineers, technologists and innovators. Launched in Vietnam in 2020, “Better Farms, Better Lives” was another initiative led by Bayer to strengthen the resilience of up to 80,000 smallholder farmers whose livelihoods and welfare have been severely impacted by COVID-19 and climate change, by providing free “Better Life Farming” care packages that are tailored to local needs. Furthermore, the company has also invested efforts in raising awareness of disease prevention and treatment, as well as strengthening access to health solutions in local communities via various collaboration programs and medical partnerships with government healthcare agencies and renowned hospitals throughout the country.
Bayer is a global enterprise with core competencies in the life science fields of health care and nutrition. Its products and services are designed to help people and planet thrive by supporting efforts to master the major challenges presented by a growing and aging global population. Bayer is committed to drive sustainable development and generate a positive impact with its businesses. At the same time, the Group aims to increase its earning power and create value through innovation and growth. The Bayer brand stands for trust, reliability and quality throughout the world. In fiscal 2021, the Group employed around 100,000 people and had sales of 44.1 billion euros. R&D expenses before special items amounted to 5.3 billion euros. For more information, go to www.bayer.com.
Pham Thi Ha Giang, phone +84 962 022 708
Tran Kim Bich Chau, phone +84 902 017 387
This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer’s public reports which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.